Download video

Brentuximab vedotin and CHP for PTCL: upcoming Phase II trial

1.2K views

VJHemOnc – Video Journal of Hematology & HemOnc

4 years ago

Brentuximab vedotin and CHP for PTCL: upcoming Phase II trial

Brentuximab vedotin and CHP for PTCL: upcoming Phase II trial

Brentuximab vedotin and CHP for PTCL: upcoming Phase II trial
2:44
Brentuximab vedotin and CHP for PTCL: upcoming Phase II trial
by VJHemOnc – Video Journal of Hematology \& HemOnc
Phase 2 trial of brentuximab vedotin plus AVD for non-bulky limited-stage Hodgkin lymphoma
3:26
Phase 2 trial of brentuximab vedotin plus AVD for non-bulky limited-stage Hodgkin lymphoma
by VJHemOnc – Video Journal of Hematology \& HemOnc
Phase II study of brentuximab vedotin + CHP in patients with PTCL with less than 10% CD30 expression
3:48
Phase II study of brentuximab vedotin + CHP in patients with PTCL with less than 10% CD30 expression
by VJHemOnc – Video Journal of Hematology \& HemOnc
ECHELON-2: brentuximab vedotin and CHP for CD30-positive T-cell lymphomas
1:32
ECHELON-2: brentuximab vedotin and CHP for CD30-positive T-cell lymphomas
by VJHemOnc – Video Journal of Hematology \& HemOnc
The Impact of Brentuximab Vedotin as PTCL Treatment
3:19
The Impact of Brentuximab Vedotin as PTCL Treatment
by OncLive
A Study Examining Brentuximab Vedotin in Patients With High-Risk Large B-Cell Lymphoma
2:51
A Study Examining Brentuximab Vedotin in Patients With High-Risk Large B-Cell Lymphoma
by Targeted Oncology
Next steps for Hodgkin lymphoma - combining brentuximab vedotin with checkpoint inhibitors
1:23
Next steps for Hodgkin lymphoma - combining brentuximab vedotin with checkpoint inhibitors
by VJHemOnc – Video Journal of Hematology \& HemOnc
PACIFIC: Brentuximab vedotin in mediastinal DLBCL
0:56
PACIFIC: Brentuximab vedotin in mediastinal DLBCL
by VJHemOnc – Video Journal of Hematology \& HemOnc
Brentuximab vedotin, nivolumab, doxorubicin \& dacarbazine for early stage classical Hodgkin lymphoma
3:23
Brentuximab vedotin, nivolumab, doxorubicin \& dacarbazine for early stage classical Hodgkin lymphoma
by VJHemOnc – Video Journal of Hematology \& HemOnc
Dr. Ai on the Efficacy of Brentuximab Vedotin in Patients With Advanced Cutaneous T-Cell Lymphoma
1:15
Dr. Ai on the Efficacy of Brentuximab Vedotin in Patients With Advanced Cutaneous T-Cell Lymphoma
by OncLive
Brentuximab vedotin with chemotherapy for advanced classical Hodgkin lymphoma
5:59
Brentuximab vedotin with chemotherapy for advanced classical Hodgkin lymphoma
by ecancer
SGN35-027: Brentuximab vedotin with nivolumab, doxorubicin, and dacarbazine in HL
2:18
SGN35-027: Brentuximab vedotin with nivolumab, doxorubicin, and dacarbazine in HL
by VJHemOnc – Video Journal of Hematology \& HemOnc
Brentuximab vedotin plus ICE as a second line treatment in R\/R Hodgkin lymphoma
1:27
Brentuximab vedotin plus ICE as a second line treatment in R\/R Hodgkin lymphoma
by VJHemOnc – Video Journal of Hematology \& HemOnc
Brentuximab Vedotin Adds Benefit to A+AVD Therapy in cHL
2:02
Brentuximab Vedotin Adds Benefit to A+AVD Therapy in cHL
by Targeted Oncology
Nivolumab-AVD vs brentuximab vedotin-AVD in pediatric patients with cHL: SWOG S1826 trial
2:20
Nivolumab-AVD vs brentuximab vedotin-AVD in pediatric patients with cHL: SWOG S1826 trial
by VJHemOnc – Video Journal of Hematology \& HemOnc
Updates on the use of brentuximab vedotin in later-stage HL
1:04
Updates on the use of brentuximab vedotin in later-stage HL
by VJHemOnc – Video Journal of Hematology \& HemOnc
Brentuximab vedotin: current status and future considerations for this agent in HL treatment
1:11
Brentuximab vedotin: current status and future considerations for this agent in HL treatment
by VJHemOnc – Video Journal of Hematology \& HemOnc
Brentuximab vedotin combined with nivolumab for Hodgkin lymphoma
1:14
Brentuximab vedotin combined with nivolumab for Hodgkin lymphoma
by VJHemOnc – Video Journal of Hematology \& HemOnc
Acceptable Safety Observed With Frontline Brentuximab Vedotin Combo in HL
0:57
Acceptable Safety Observed With Frontline Brentuximab Vedotin Combo in HL
by Targeted Oncology
Advantages of Brentuximab Vedotin and Chemotherapy Combination for Advanced Stage Hodgkin Lymphoma
0:57
Advantages of Brentuximab Vedotin and Chemotherapy Combination for Advanced Stage Hodgkin Lymphoma
by Rare Disease Report